Tag
2 articles
The world's oldest cord blood bank is building a stem cell platform that could revolutionize regenerative medicine by transforming discarded cord blood into patient-specific iPSCs.
HexemBio raises $10.4M to develop a novel stem cell rejuvenation therapy targeting blood cancers through a Nature-published approach that recreates embryonic conditions.
